• Mitigating Pollen Spectral Interference in Bioaerosol Detect

  2026-05-23

  Zhang et al. (2024) present a robust method to identify and remove pollen-induced spectral interference in hazardous substance classification using excitation–emission matrix fluorescence spectroscopy (EEM). Their approach combines advanced spectral preprocessing and a random forest algorithm, significantly improving the accurate detection of harmful bioaerosols in complex environments.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–Receptor Bindi

  2026-05-22

  Oliveira et al. (2025) reveal that specific angiotensin peptides, particularly shorter fragments derived from the renin-angiotensin system, significantly enhance SARS-CoV-2 spike protein binding to host cell receptors, especially AXL. This finding highlights a novel interface between cardiovascular peptide signaling and viral pathogenesis, with important implications for COVID-19 research and therapeutic targeting.

• Decitabine Enhances Anti–PD-1 Efficacy via CD8+ Progenitor T

  2026-05-22

  This study demonstrates that Decitabine priming before anti–PD-1 therapy promotes the expansion and function of CD8+ progenitor exhausted T cells, leading to improved antitumor efficacy in preclinical models. The findings provide mechanistic insight into how epigenetic modulation can enhance immune checkpoint blockade responses, with implications for cancer immunotherapy research.

• HR-LCMS/MS Reveals Astragalus dasyanthus as a Glabrol Source

  2026-05-21

  This study developed a streamlined HR-LCMS/MS-based workflow for rapid identification of autophagy-inducing compounds in plant extracts, using SH-SY5Y cells as an activity screen. The authors uncovered Astragalus dasyanthus as a novel source of the autophagy inducer glabrol, demonstrating an effective method for dereplication and high-throughput screening of bioactive phytochemicals.

• Site-Specific Biotinylation of IL7 Preserves Bioactivity and

  2026-05-21

  This study presents a prokaryotic AviTag/BirA system enabling site-specific biotinylation of interleukin-7 (IL7), in contrast to conventional random chemical biotinylation that often impairs protein function. The approach minimizes activity loss, preserves antibody binding, and enhances the utility of biotin-IL7 in immunological and therapeutic applications.

• SIS3 (Smad3 Inhibitor): Precision Tool for Fibrosis Research

  2026-05-20

  SIS3, a highly selective Smad3 inhibitor from APExBIO, enables targeted modulation of the TGF-β signaling pathway, supporting advanced fibrosis and osteoarthritis research. Its robust selectivity and validated in vitro and in vivo efficacy streamline experimental workflows and reveal new mechanistic insights.

• CLCC1 Identified as Key Host Factor in Herpesvirus Nuclear E

  2026-05-20

  The referenced study uncovers CLCC1 as an essential host protein for the membrane fusion step of herpesvirus nuclear egress, revealing a previously unknown mechanism critical for viral replication. These findings provide a new cellular target for antiviral research and inform the development of immunomodulatory interventions.

• Exemestane in Translational Breast Cancer: Mechanisms & Stra

  2026-05-19

  This thought-leadership article dissects exemestane’s molecular mechanism as a steroidal aromatase inhibitor and delivers strategic guidance for translational researchers. By integrating recent evidence, competitive landscape analysis, and hands-on workflow advice, we provide a roadmap for leveraging APExBIO’s exemestane in the evolving landscape of breast cancer research. The discussion bridges mechanistic insight with practical protocols and forward-looking perspectives, highlighting how this piece advances beyond conventional product content.

• Senescence Genes as Diagnostic Signatures in Abdominal Aorti

  2026-05-19

  This study pioneers the identification of cellular senescence-associated genes, particularly ETS1 and ITPR3, as robust diagnostic biomarkers for abdominal aortic aneurysm (AAA). By integrating large-scale transcriptomic analyses with machine learning and multi-cohort validation, the research advances early detection strategies and offers insights for targeted therapeutic development.

• Exemestane: Selective Steroidal Aromatase Inhibition in Rese

  2026-05-18

  Exemestane is a potent, selective, and irreversible steroidal aromatase inhibitor. It is widely employed for estrogen biosynthesis inhibition in breast cancer research. This article details its mechanism, evidence basis, and best practices for laboratory use.

• IR-1061 Near Infrared Fluorescent Dye for Deep Tissue Imagin

  2026-05-18

  IR-1061 sets a new benchmark among near infrared fluorescent dyes by enabling high-clarity, deep tissue in vivo imaging with minimal background. Its unique photophysical properties, proven in advanced liposomal encapsulation protocols, empower synergistic imaging-therapy workflows that reimagine molecular imaging in biomedical research.

• Nadolol (SQ-11725) in Advanced Cardiovascular Research Workf

  2026-05-17

  Unlock the experimental potential of Nadolol (SQ-11725) for hypertension, angina pectoris, and vascular headache research. This guide delivers actionable protocols, transporter-focused insights, and troubleshooting solutions—empowering labs to optimize beta-adrenergic signaling studies with APExBIO's rigorously validated compound.

• 3D DNA Frameworks Enhance Enzymatic Oligonucleotide Synthesi

  2026-05-16

  A recent study introduces tetrahedral DNA nanostructures (TDN) as organized scaffolds for enzymatic oligonucleotide synthesis (EOS), significantly improving enzyme accessibility and synthesis fidelity. This innovation enables longer, high-yield DNA synthesis with reduced errors, paving the way for advanced DNA data storage and genetic applications.

• Angiotensin Peptides Facilitate SARS-CoV-2 Spike–AXL Binding

  2026-05-15

  Oliveira et al. (2025) reveal that naturally occurring angiotensin peptides, including truncated forms such as Angiotensin 1/2 (5-7), significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor, potentially influencing viral entry in host cells. These findings bridge renin-angiotensin system research with emerging questions in COVID-19 pathogenesis and highlight novel therapeutic targets.

• Angiotensin 1/2 (5-7): Novel Insights for Cardiovascular and

  2026-05-15

  Explore the multifaceted research potential of Angiotensin 1/2 (5-7), a key peptide for RAS and hypertension studies. This article offers new perspectives on assay design, molecular mechanisms, and cross-domain implications for cardiovascular and SARS-CoV-2 research.

16117 records 1/1075 page Next 12345 下5页 Last page